Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.

NCT00385138 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5364

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient evidence of the clinical effectiveness of cangrelor

Conditions

Atherosclerosis
Acute Coronary Syndrome (ACS)

Interventions

DRUG: Cangrelor
DRUG: clopidogrel
DRUG: Placebo bolus & placebo infusion
DRUG: Placebo capsules - end of PCI
DRUG: Placebo capsules - end of infusion

Sponsor

The Medicines Company